Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: An unpredicted novel function of cytomegalovirus

Journal of Virology

Volumn 76, Issue 6, 2002, Pages 2857-2870

  Erlach, Katja C ^a   Podlech, Jürgen ^a   Rojan, Aysel ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD8 ANTIGEN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER CELL; CANCER CONTROL; CANCER GROWTH; CANCER INFILTRATION; CANCER INHIBITION; CANCER MODEL; CANCER RECURRENCE; CANCER REGRESSION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOPATHOGENIC EFFECT; FEMALE; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; LIVER; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036184798     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.6.2857-2870.2002     Document Type: Article

References (67)

1. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis
2. The effect of cytomegalovirus on hematopoiesis: In vitro evidence for selective infection of marrow stromal cells
3. Oncolytic viral anti-cancer therapy: A magic bullet?
4. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism
5. Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma
6. Cytomegalovirus infection and compromise
7. 1/S transition
8. Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients
9. The significance of cytomegalovirus infection over the clinical course of adult T-cell leukemia/lymphoma
10. Cytomegalovirus infection is not necessarily a poor prognostic factor in adult T-cell leukemia/lymphoma
11. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis
12. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
13. Caspases: Key players in programmed cell death
14. Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen
15. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis
16. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
17. d haplotype
18. Human cytomegalovirus productively infects primary differentiated macrophages
19. Biology of disease. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin
20. CD45: A family of leukocyte-specific cell surface glycoproteins
21. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
22. Establishment and characterization of BALB/c lymphoma lines with B cell properties
23. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
24. Local control of the immune response in the liver
25. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
26. The bacterial lacZ gene: An important tool for metastasis research and evaluation of new cancer therapies
27. Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs
28. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian, and murine cytomegalovirus
29. Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection
30. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models
31. Cytomegalovirus infection
32. Factors influencing the outcome of bone marrow transplants using unrelated donors
33. Identity of the proliferating cell nuclear antigen and cyclin
34. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of stromal hemopoietin genes
35. Dysregulation of cyclin E gene expression in human cytomegalovirus-infected cells requires viral early gene expression and is associated with changes in the Rb-related protein p130
36. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow
37. Cytomegaloviruses and their replication
38. Failure in generating hematopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host
39. Apoptin
40. Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12
41. Cell types involved in replication and distribution of human cytomegalovirus
42. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: Persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection
43. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation
44. Clinical applicability of the evaluation of minimal residual disease in acute leukemia
45. The immunogenicity of human and murine cytomegaloviruses
46. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
47. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10
48. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts
49. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus
50. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host
51. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1 alpha (MIP-1alpha)-dependent pathways
52. Detection of minimal residual disease in acute leukemia
53. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B
54. Mechanisms of cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells
55. Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells
56. Tissue macrophages are infected by human cytomegalovirus in vivo
57. Detection of apoptosis in tissue sections
58. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence
59. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hematopoietin gene expression in recipient stroma
60. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus
61. Interactions between cancer cells and the microvasculature: A rate-regulator for metastasis
62. Viruses as antitumor weapons: Defining conditions for tumor remission
63. Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays